PVG Asset Management’s Anavex Life Sciences AVXL Stock Holding History

PVG Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$848K	Sell	327,344 -200	-0.1%	-$592	0.49%	59
2026 Q1	$819K	Buy	327,544 +111,249	+51%	+$482K	0.48%	59
2025 Q4	$770K	Buy	216,295 +83,147	+62%	+$509K	1.64%	16
2025 Q3	$1.19M	Buy	133,148 +21,703	+19%	+$220K	4.36%	2
2025 Q2	$1.03M	Buy	111,445 +28,837	+35%	+$246K	3.5%	4
2025 Q1	$709K	Buy	82,608 +4,118	+5%	+$38.9K	3.09%	9
2024 Q4	$843K	Buy	78,490 +65,485	+504%	+$504K	3.99%	5
2024 Q3	$73.9K	Buy	+13,005	New	+$75K	0.3%	40

Other funds holding AVXL

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

SSWM

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

LexAurum Advisors Overland Park, Kansas $866M AUM

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

CIC

Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

PVG Asset Management's AVXL Position: Q2 2026 in Review

PVG Asset Management reduced its Anavex Life Sciences (AVXL) stake by 0.06% in Q2 2026, selling an estimated $592 and leaving 327,344 shares worth $848K. The position accounts for 0.49% of the portfolio, ranked #59.

PVG Asset Management first reported a position in AVXL in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.19M in Q3 2025. 40 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

PVG Asset Management held 327,344 shares of Anavex Life Sciences worth $848K as of Q2 2026.
PVG Asset Management sold 200 Anavex Life Sciences shares in Q2 2026, an estimated $592.
Anavex Life Sciences made up 0.49% of PVG Asset Management's portfolio in Q2 2026, its #59 holding.
PVG Asset Management first reported a position in Anavex Life Sciences in Q3 2024 and has held it in 8 quarters since.
PVG Asset Management's Anavex Life Sciences position peaked at $1.19M in Q3 2025.
40 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on PVG Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.